Compass Pathways PLC

5Y6

Company Profile

  • Business description

    Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

  • Contact

    33 Broadwick Street
    LondonW1F 0DQ
    GBR

    E: [email protected]

    https://compasspathways.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Care Facilities

    Fiscal Year End

    31 December 2026

    Employees

    166

Stocks News & Analysis

stocks

Finding yield on the ASX

The ASX, known for its yield appeal is at its lowest level in 20 years. Here’s why, and what investors should do.
stocks

ExxonMobil earnings: Continued execution, on track for 2030 targets

We’ve raised our fair value estimate of Exxon stock.
stocks

Disney earnings: No big surprises in solid results

Growth in areas critical to the firm’s future.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,149.306.90-0.08%
CAC 408,181.1754.640.67%
DAX 4024,797.52258.711.05%
Dow JONES (US)49,407.66515.191.05%
FTSE 10010,341.56118.021.15%
HKSE26,848.9473.370.27%
NASDAQ23,592.11130.290.56%
Nikkei 22554,720.662,065.483.92%
NZX 50 Index13,421.529.080.07%
S&P 5006,976.4437.410.54%
S&P/ASX 2008,857.109.20-0.10%
SSE Composite Index4,067.7451.991.29%

Market Movers